These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 28510271)

  • 1. Application of Combination High-Throughput Phenotypic Screening and Target Identification Methods for the Discovery of Natural Product-Based Combination Drugs.
    Isgut M; Rao M; Yang C; Subrahmanyam V; Rida PCG; Aneja R
    Med Res Rev; 2018 Mar; 38(2):504-524. PubMed ID: 28510271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applied metabolomics in drug discovery.
    Cuperlovic-Culf M; Culf AS
    Expert Opin Drug Discov; 2016 Aug; 11(8):759-70. PubMed ID: 27366968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel drug targets and their functions using phenotypic screening of natural products.
    Chang J; Kwon HJ
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):221-31. PubMed ID: 26364198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural products as probes in pharmaceutical research.
    Schmitt EK; Hoepfner D; Krastel P
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):249-60. PubMed ID: 26438431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics for bioactivity assessment of natural products.
    Yuliana ND; Khatib A; Choi YH; Verpoorte R
    Phytother Res; 2011 Feb; 25(2):157-69. PubMed ID: 20658470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural products as a foundation for drug discovery.
    Beutler JA
    Curr Protoc Pharmacol; 2009 Sep; Chapter 9():Unit 9.11. PubMed ID: 22294405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
    Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
    J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into drug discovery from natural medicines using reverse pharmacokinetics.
    Hao H; Zheng X; Wang G
    Trends Pharmacol Sci; 2014 Apr; 35(4):168-77. PubMed ID: 24582872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of chemical biology in target identification and drug discovery.
    Zhu Y; Xiao T; Lei S; Zhou F; Wang MW
    Arch Pharm Res; 2015 Sep; 38(9):1642-50. PubMed ID: 26242900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network-Based Drug Discovery: Coupling Network Pharmacology with Phenotypic Screening for Neuronal Excitability.
    Sidders B; Karlsson A; Kitching L; Torella R; Karila P; Phelan A
    J Mol Biol; 2018 Sep; 430(18 Pt A):3005-3015. PubMed ID: 30030026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Considerations of the chemical biology of microbial natural products provide an effective drug discovery strategy.
    Choi H; Oh DC
    Arch Pharm Res; 2015 Sep; 38(9):1591-605. PubMed ID: 26231248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NCI Program for Natural Product Discovery: A Publicly-Accessible Library of Natural Product Fractions for High-Throughput Screening.
    Thornburg CC; Britt JR; Evans JR; Akee RK; Whitt JA; Trinh SK; Harris MJ; Thompson JR; Ewing TL; Shipley SM; Grothaus PG; Newman DJ; Schneider JP; Grkovic T; O'Keefe BR
    ACS Chem Biol; 2018 Sep; 13(9):2484-2497. PubMed ID: 29812901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational screening of peroxisome proliferator-activated receptor-γ agonists from natural products: potential therapeutics for heart failure.
    Chen R; Wan J; Song J; Qian Y; Liu Y; Gu S
    Pharm Biol; 2017 Dec; 55(1):503-509. PubMed ID: 27937122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The polypharmacology of natural products.
    Ho TT; Tran QT; Chai CL
    Future Med Chem; 2018 Jun; 10(11):1361-1368. PubMed ID: 29673257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of natural products as chemical library for drug discovery and network pharmacology.
    Gu J; Gui Y; Chen L; Yuan G; Lu HZ; Xu X
    PLoS One; 2013; 8(4):e62839. PubMed ID: 23638153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CETSA and thermal proteome profiling strategies for target identification and drug discovery of natural products.
    Tu Y; Tan L; Tao H; Li Y; Liu H
    Phytomedicine; 2023 Jul; 116():154862. PubMed ID: 37216761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Data Resources for the Computer-Guided Discovery of Bioactive Natural Products.
    Chen Y; de Bruyn Kops C; Kirchmair J
    J Chem Inf Model; 2017 Sep; 57(9):2099-2111. PubMed ID: 28853576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural product derived privileged scaffolds in drug discovery.
    Davison EK; Brimble MA
    Curr Opin Chem Biol; 2019 Oct; 52():1-8. PubMed ID: 30682725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular approaches towards development of purified natural products and their structurally known derivatives as efficient anti-cancer drugs: current trends.
    Saha SK; Khuda-Bukhsh AR
    Eur J Pharmacol; 2013 Aug; 714(1-3):239-48. PubMed ID: 23819913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragment-based screening with natural products for novel anti-parasitic disease drug discovery.
    Liu M; Quinn RJ
    Expert Opin Drug Discov; 2019 Dec; 14(12):1283-1295. PubMed ID: 31512943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.